Taylor Patrick Light

Taylor Patrick Light

Auto-generated profile, based on publicly available information

Taylor Patrick Light

Department of Chemistry and Biochemistry, James Madison University , Harrisonburg, Virginia 22807, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
BSBrendan Sullivan
Brendan Sullivan
TLTaylor Light
Taylor Light
VVVinh Vu
Vinh Vu
AKAdrian Kapustka
Adrian Kapustka
KHKalina Hristova
Kalina Hristova
DLDeborah Leckband
Deborah Leckband
Significance: Force transduction at interepithelial junctions involves E-cadherin–mediated activation of epidermal growth factor receptor (EGFR) signaling, which modulates local cytoskeletal remodeling and cell proliferation. Findings show that E-cadherin and EGFR form a heteroreceptor complex at the membrane. Increased tension on E-cadherin bonds disrupts the complex in the absence of epidermal growth factor (EGF), but the mechanical activation of EGFR signaling requires soluble EGF. Fully quantified spectral imaging fluorescence resonance energy transfer measurements further revealed that E-cadherin and EGFR form a heterotrimeric complex at the plasma membrane, comprising two E-cadherins bound to an EGFR monomer. These results suggest that tugging forces on E-cadherin adhesions activate force transduction cascades, by releasing EGFR monomers from the complex, to enable EGFR to homodimerize, bind EGF, and signal.
1

2 December 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
BLBernhard C. Lechtenberg
Bernhard C. Lechtenberg
MGMarina P. Gehring
Marina P. Gehring
TLTaylor P. Light
Taylor P. Light
CHChristopher R. Horne
Christopher R. Horne
MMMike W. Matsumoto
Mike W. Matsumoto
EPElena Pasquale
Elena Pasquale
Eph receptor tyrosine kinases play a key role in cell-cell communication. Lack of structural information on the entire multi-domain intracellular region of any Eph receptor has hindered understanding of their signaling mechanisms. Here, we use integrative structural biology to investigate the structure and dynamics of the EphA2 intracellular region. EphA2 promotes cancer malignancy through a poorly understood non-canonical form of signaling involving serine/threonine phosphorylation of the linker connecting its kinase and SAM domains. We show that accumulation of multiple linker negative charges, mimicking phosphorylation, induces cooperative changes in the EphA2 intracellular region from more closed to more extended conformations and perturbs the EphA2 juxtamembrane segment and kinase domain. In cells, linker negative charges promote EphA2 oligomerization. We also identify multiple kinases catalyzing linker phosphorylation. Our findings suggest multiple effects of linker phosphorylation on EphA2 signaling and imply that coordination of different kinases is necessary to promote EphA2 non-canonical signaling.

1 August 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MFMaría L. Franco
María L. Franco
KNKirill D. Nadezhdin
Kirill D. Nadezhdin
TLTaylor P. Light
Taylor P. Light
SGSergey A. Goncharuk
Sergey A. Goncharuk
ASAndrea Soler-Lopez
Andrea Soler-Lopez
MVMarçal Vilar
Marçal Vilar
The neurotrophin receptors p75 and tyrosine protein kinase receptor A (TrkA) play important roles in the development and survival of the nervous system. Biochemical data suggest that p75 and TrkA reciprocally regulate the activities of each other. For instance, p75 is able to regulate the response of TrkA to lower concentrations of nerve growth factor (NGF), and TrkA promotes shedding of the extracellular domain of p75 by α-secretases in a ligand-dependent manner. The current model suggests that p75 and TrkA are regulated by means of a direct physical interaction; however, the nature of such interaction has been elusive thus far. Here, using NMR in micelles, multiscale molecular dynamics, FRET, and functional studies, we identified and characterized the direct interaction between TrkA and p75 through their respective transmembrane domains (TMDs). Molecular dynamics of p75-TMD mutants suggests that although the interaction between TrkA and p75 TMDs is maintained upon mutation, a specific protein interface is required to facilitate TrkA active homodimerization in the presence of NGF. The same mutations in the TMD protein interface of p75 reduced the activation of TrkA by NGF as well as reducing cell differentiation. In summary, we provide a structural model of the p75-TrkA receptor complex necessary for neuronal development stabilized by TMD interactions.

26 January 2016 in Langmuir
Verified
Journal Article
Closed access
TLTaylor Patrick Light
Taylor Patrick Light
KCKaren Marie Corbett
Karen Marie Corbett
MMMichael A. Metrick
Michael A. Metrick
GMGina MacDonald
Gina MacDonald

8 February 2017 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
NJNicolas O. Johnson
Nicolas O. Johnson
TLTaylor P. Light
Taylor P. Light
GMGina MacDonald
Gina MacDonald
YZYanjie Zhang
Yanjie Zhang

1 July 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TLTaylor P. Light
Taylor P. Light
MGMaricel Gomez-Soler
Maricel Gomez-Soler
ZWZichen Wang
Zichen Wang
KKKelly Karl
Kelly Karl
EZElmer Zapata-Mercado
Elmer Zapata-Mercado
EPElena Pasquale
Elena Pasquale
The Eph receptor tyrosine kinases and their ephrin ligands regulate many physiological and pathological processes. EphA4 plays important roles in nervous system development and adult homeostasis, while aberrant EphA4 signaling has been implicated in neurodegeneration. EphA4 may also affect cancer malignancy, but the regulation and effects of EphA4 signaling in cancer are poorly understood. A correlation between decreased patient survival and high EphA4 mRNA expression in melanoma tumors that also highly express ephrinA ligands suggests that enhanced EphA4 signaling may contribute to melanoma progression. A search for EphA4 gain-of-function mutations in melanoma uncovered a mutation of the highly conserved leucine 920 in the EphA4 sterile alpha motif (SAM) domain. We found that mutation of L920 to phenylalanine (L920F) potentiates EphA4 autophosphorylation and signaling, making it the first documented EphA4 cancer mutation that increases kinase activity. Quantitative Föster resonance energy transfer and fluorescence intensity fluctuation (FIF) analyses revealed that the L920F mutation induces a switch in EphA4 oligomer size, from a dimer to a trimer. We propose this switch in oligomer size as a novel mechanism underlying EphA4-linked tumorigenesis. Molecular dynamics simulations suggest that the L920F mutation alters EphA4 SAM domain conformation, leading to the formation of EphA4 trimers that assemble through two aberrant SAM domain interfaces. Accordingly, EphA4 wild-type and the L920F mutant are affected differently by the SAM domain and are differentially regulated by ephrin ligand stimulation. The increased EphA4 activation induced by the L920F mutation, through the novel mechanism we uncovered, supports a functional role for EphA4 in promoting pathogenesis.